Use of recombinant granulocyte-macrophage colony-stimulating factor during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia (AML)

B. Löwenberg, S. Suciu, E. Archimbaud, G. Ossenkoppele, G.E.G. Verhoef, E. Vellenga, P.W. Wijermans, Z. Berneman, A.W. Dekker, P. Stryckmans, H.C. Schouten, U. Jehn, P. Muus, P. Sonneveld, M. Dardenne, R. Zittoun

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2952-2961
Number of pages10
JournalBlood
Volume90
Publication statusPublished - 1997

Keywords

  • Econometric and Statistical Methods: General
  • Geneeskunde(GENK)
  • Algemeen onderzoek
  • Immunology

Cite this